Related Experiment Video
Updated: Feb 14, 2026

Cultivate Primary Nasal Epithelial Cells from Children and Reprogram into Induced Pluripotent Stem Cells
Published on: March 10, 2016
Mutational analysis of AGXT gene in Libyan children with primary hyperoxaluria type 1 at Tripoli Children Hospital
Naziha R Rhuma1, Omar A Fituri1, Laila T Sabei2
1Department of Pediatrics and Faculty of Medicine, University of Tripoli, Tripoli, Libya.
Insights
Primary hyperoxaluria type 1 (PH1) is a genetic metabolic disorder. The common AGXT gene mutation c.731T>C in Libyan children is linked to high consanguinity rates, necessitating genetic counseling.
Area of Science:
- Pediatric Nephrology
- Medical Genetics
- Inborn Errors of Metabolism
Background:
- Primary hyperoxaluria type 1 (PH1) is a rare genetic disorder affecting glyoxylate metabolism.
- It stems from mutations in the AGXT gene, leading to oxalate overproduction and kidney damage.
- Understanding the clinical and genetic landscape of PH1 is crucial for early diagnosis and management.
Purpose of the Study:
- To investigate the clinical and epidemiological characteristics of PH1 in Libyan children.
- To identify the specific AGXT gene mutations prevalent in this population.
- To correlate genetic findings with clinical presentation and family history.
Main Methods:
- A descriptive case series of 53 Libyan children diagnosed with PH1 between 1994 and 2015.
- Diagnosis was based on clinical signs (kidney stones, nephrocalcinosis), family history, and elevated urinary oxalate.
- AGXT gene mutation analysis was performed on collected samples.
Main Results:
- The study identified 53 pediatric PH1 cases, with males comprising 62.3%.
- High consanguinity rates (81.1%) were observed, particularly in children from the South West region.
- The c.731T>C (p.Ile244Thr) mutation was the most frequent (71%), often homozygous and associated with family history and younger age at presentation.
Conclusions:
- The c.731T>C mutation is the predominant AGXT mutation in Libyan children with PH1.
- High consanguinity likely contributes to the prevalence of this specific mutation.
- Genetic counseling is recommended for families affected by PH1 due to the high rate of consanguinity.
Abstract:
Primary hyperoxaluria type 1 (PH1) is an inborn error of glyoxylate metabolism. It results from genetic mutation of the AGXT gene. The study objective was to verify the clinical and epidemiological patterns of PH1 in Libyan children at Tripoli Children Hospital confirmed by AGXT gene mutation. A descriptive case series study of 53 children with PH1 diagnosed between 1994 and 2015 was carried out in the Nephrology Unit at Tripoli Children Hospital. Diagnosis of PH1 was based on the clinical presentation (renal stones or nephrocalcinosis), positive family history of PH1, and high 24 h urinary oxalate. Sampling for AGXT gene mutation was collected from April 2012 to December. 2015. Among the 53 children included, males composed of 62.3% of patients. Their age at presentation ranged between two months and 20 years with a mean age of 55.4 ± 48 months. The parents of 81.1% of these patients had positive consanguinity. Forty (75.5%) patients were from South West (mountain area), and 16 (40%) of them were from Yefrin. The most common mutation found in this study was c.731T>C (p.lle244thr) seen in 32 (71%) of children, and interestingly, among these patients, 87.1% were homozygous in gene typing, 86.2% had positive history of consanguinity, 71.4% were from South West (mountain area), 96.6% had family history of PH1, and 20% presented with impaired renal function. The patients with this mutation were younger at presentation than that with other genes, and it was more prevalent among boys (61.3%). Thus, the most common gene mutation found in Libyan children with PH1 was c.731T>C (p.lle244thr) and this is more likely due to the strong genetic pooling caused by the high consanguinity rate which requires an extensive genetic counseling.
Related Concept Videos
Drug Dosing: Infants and Children
Mutation, Gene Flow, and Genetic Drift
Hospitals-II
Nurses that work in...
Pedigree Analysis
Hospitals-I
Mutations

